These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37963312)

  • 1. NS1-Specific Antibody Response Facilitates the Identification of Children With Dengue and Zika in Hyperendemic Areas.
    Castro-Trujillo S; Segura K; Bolívar-Marín S; Salgado DM; Bosch I; Vega R; Rojas MC; Narváez CF
    Pediatr Infect Dis J; 2024 Feb; 43(2):178-185. PubMed ID: 37963312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinguishing Secondary Dengue Virus Infection From Zika Virus Infection With Previous Dengue by a Combination of 3 Simple Serological Tests.
    Tsai WY; Youn HH; Brites C; Tsai JJ; Tyson J; Pedroso C; Drexler JF; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK
    Clin Infect Dis; 2017 Nov; 65(11):1829-1836. PubMed ID: 29020159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-evaluation of routine dengue virus serology in travelers in the era of Zika virus emergence.
    van Meer MPA; Mögling R; Klaasse J; Chandler FD; Pas SD; van der Eijk AA; Koopmans MPG; Reusken CBEM; GeurtsvanKessel CH
    J Clin Virol; 2017 Jul; 92():25-31. PubMed ID: 28505571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of Nonstructural Protein 1-Based Enzyme-Linked Immunosorbent Assays Can Detect and Distinguish Various Dengue Virus and Zika Virus Infections.
    Tyson J; Tsai WY; Tsai JJ; Brites C; Mässgård L; Ha Youn H; Pedroso C; Drexler JF; Stramer SL; Balmaseda A; Harris E; Wang WK
    J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30429254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Evaluation of Differential Serodiagnosis between Zika and Dengue Viral Infections.
    Chao DY; Whitney MT; Davis BS; Medina FA; Munoz JL; Chang GJ
    J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30541932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections.
    Hsieh SC; Tsai WY; Tsai JJ; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK
    J Virol; 2021 Sep; 95(19):e0061921. PubMed ID: 34232731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016.
    Steinhagen K; Probst C; Radzimski C; Schmidt-Chanasit J; Emmerich P; van Esbroeck M; Schinkel J; Grobusch MP; Goorhuis A; Warnecke JM; Lattwein E; Komorowski L; Deerberg A; Saschenbrecker S; Stöcker W; Schlumberger W
    Euro Surveill; 2016 Dec; 21(50):. PubMed ID: 28006649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Anti-Dengue and Anti-Zika IgG on a Plasmonic Gold Platform with Neutralization Testing.
    Rojas A; Natrajan MS; Weber J; Cardozo F; Cantero C; Ananta JS; Kost J; Tang M; López S; Bernal C; Guillén Y; Mendoza L; Páez M; Pinsky BA; Waggoner JJ
    Am J Trop Med Hyg; 2021 Mar; 104(5):1729-1733. PubMed ID: 33782214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capacity of a Multiplex IgM Antibody Capture ELISA to Differentiate Zika and Dengue Virus Infections in Areas of Concurrent Endemic Transmission.
    Medina FA; Vila F; Premkumar L; Lorenzi O; Paz-Bailey G; Alvarado LI; Rivera-Amill V; de Silva A; Waterman S; Muñoz-Jordán J
    Am J Trop Med Hyg; 2021 Dec; 106(2):585-592. PubMed ID: 34929668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Added value of IgA antibodies against Zika virus non-structural protein 1 in the diagnosis of acute Zika virus infections.
    Warnecke JM; Lattwein E; Saschenbrecker S; Stöcker W; Schlumberger W; Steinhagen K
    J Virol Methods; 2019 May; 267():8-15. PubMed ID: 30779938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of eight commercial Zika virus IgM and IgG serology assays for diagnostics and research.
    Low SL; Leo YS; Lai YL; Lam S; Tan HH; Wong JCC; Tan LK; Ng LC
    PLoS One; 2021; 16(1):e0244601. PubMed ID: 33497414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perinatal analyses of Zika- and dengue virus-specific neutralizing antibodies: A microcephaly case-control study in an area of high dengue endemicity in Brazil.
    Castanha PMS; Souza WV; Braga C; Araújo TVB; Ximenes RAA; Albuquerque MFPM; Montarroyos UR; Miranda-Filho DB; Cordeiro MT; Dhalia R; Marques ETA; Rodrigues LC; Martelli CMT;
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007246. PubMed ID: 30856223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the immunoglobulin G avidity assay to differentiate between recent Zika and past dengue virus infections.
    Furuya AKM; Hunt D; George KS; Dupuis AP; Kramer LD; Shi PY; Wong S
    Clin Sci (Lond); 2019 Apr; 133(7):859-867. PubMed ID: 30902827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of diagnostic and analytic performance of the SD Bioline Dengue Duo test for dengue virus (DENV) infections in an endemic area (Savannakhet province, Lao People's Democratic Republic).
    Blessmann J; Winkelmann Y; Keoviengkhone L; Sopraseuth V; Kann S; Hansen J; El Halas H; Emmerich P; Schmidt-Chanasit J; Schmitz H; Mika A; Deschermeier C
    PLoS One; 2020; 15(3):e0230337. PubMed ID: 32182271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of Zika virus infection on a nanotechnology platform.
    Zhang B; Pinsky BA; Ananta JS; Zhao S; Arulkumar S; Wan H; Sahoo MK; Abeynayake J; Waggoner JJ; Hopes C; Tang M; Dai H
    Nat Med; 2017 May; 23(5):548-550. PubMed ID: 28263312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zika Virus Disease Comparing Children and Adults in a Dengue-Endemic Setting.
    Wongsawat J; Vivong N; Suttha P; Utayamakul S; Aumpornareekul S; Chewcharat A; Chokephaibulkit K
    Am J Trop Med Hyg; 2020 Nov; 104(2):557-563. PubMed ID: 33241785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed and highly specific antibody response to nonstructural protein 1 (NS1) revealed during natural human ZIKV infection by NS1-based capture ELISA.
    Gao X; Wen Y; Wang J; Hong W; Li C; Zhao L; Yin C; Jin X; Zhang F; Yu L
    BMC Infect Dis; 2018 Jun; 18(1):275. PubMed ID: 29898684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of serological and molecular methods for diagnosis of zika virus infections.
    Jääskeläinen AJ; Korhonen EM; Huhtamo E; Lappalainen M; Vapalahti O; Kallio-Kokko H
    J Virol Methods; 2019 Jan; 263():68-74. PubMed ID: 30342068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of IgG Depletion in a Neutralization Assay Facilitates Differential Diagnosis of Zika and Dengue in Secondary Flavivirus Infection Cases.
    Calvert AE; Boroughs KL; Laven J; Stovall JL; Luy BE; Kosoy OI; Huang CY
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-structural protein 1 from Zika virus: Heterologous expression, purification, and potential for diagnosis of Zika infections.
    Magalhães ICL; Marques LEC; Souza PFN; Girão NM; Herazo MMA; Costa HPS; vanTilburg MF; Florean EOPT; Dutra RF; Guedes MIF
    Int J Biol Macromol; 2021 Sep; 186():984-993. PubMed ID: 34293361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.